Back to 
MetLife Investment Management, LLC
MetLife Investment Management, LLC
KPTI
1 quarters
Position history for MetLife Investment Management, LLC's holdings in Karyopharm Therapeutics Inc.
Yes. MetLife Investment Management holds 12,017 shares of KPTI (Karyopharm Therapeutics), worth $117,406, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$117,406
Current Shares
12,017
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of KPTI: RA Capital Management, L.P., Adage Capital Partners GP, L.L.C., Goldman Sachs Group Inc., BlackRock, Inc.